cyproterone acetate has been researched along with cyproterone acetate, ethinyl estradiol drug combination in 142 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (23.24) | 18.7374 |
| 1990's | 24 (16.90) | 18.2507 |
| 2000's | 33 (23.24) | 29.6817 |
| 2010's | 45 (31.69) | 24.3611 |
| 2020's | 7 (4.93) | 2.80 |
| Authors | Studies |
|---|---|
| Brändle, E; Gottwald, E; Melzer, H; Sieberth, HG | 1 |
| Laatikainen, T; Seppälä, M; Stenman, UH; Suikkari, AM; Tiitinen, A | 1 |
| Cunningham, SK; McKenna, TJ | 1 |
| Burrows, D; Eedy, DJ | 1 |
| Brun, JG; Seroka, J | 1 |
| Gruner, S; Kaiser, E | 1 |
| Wishart, JM | 1 |
| Beaucaire, G; Beuscart, C; Brion, M; Leroy, O; Senneville, E; Tillie, I; Visticot, F | 1 |
| Falsetti, L; Galbignani, E | 1 |
| Egyedi, K; Kása, M; Raffai, S; Török, L | 1 |
| Balint-Perić, L; Prelević, GM; Trpković, D; Würzburger, MI | 1 |
| Koh, SC; Ratnam, SS; Tsakok, FH | 1 |
| Borradori, L; Marie, O; Morel, P; Rybojad, M; Späth, P; Vexiau, P | 1 |
| Balint-Perić, L; Prelević, GM; Puzigaća, Z; Würzburger, MI | 1 |
| Ernst, E; Matrai, A; Schmölzl, C; Schramm, W | 1 |
| Hammerstein, J | 1 |
| Bye, P | 2 |
| Cunliffe, WJ | 1 |
| Rajka, G | 1 |
| Ashton, RE; Dowd, PM; Griffiths, WA; Jacobs, HS; Miller, JA; O'Brien, TJ; Wojnarowska, FT | 1 |
| Meyrick, RL | 1 |
| Aydinlik, S; Lachnit-Fixson, U; Lehnert, J | 1 |
| Guber, A; Poran, J; Schindler, D; Shachor, Y | 1 |
| Korchevaia, TA; Kravchenko, LIa; Rubina, VV | 1 |
| Belisle, S; Love, EJ | 1 |
| Kaiser, E | 1 |
| Carlborg, L | 1 |
| Montanari, L; Pelfini, C; Vignini, M | 1 |
| Mehrl, J | 1 |
| Rubens, R; Vermeulen, A | 1 |
| Arzt, W; Mursch-Edlmayr, G; Tews, G | 1 |
| Huber, J; Schmidt, JB; Spona, J | 1 |
| Abbate, R; Bruni, V; Bucciantini, S; Costanzo, G; Costanzo, M; Pinto, S; Rosati, D; Verni, A | 1 |
| Baglioni, A; Cavalli, G; Fedele, L; Marchini, M; Taccagni, GL | 1 |
| Djøseland, O; Lunde, O | 1 |
| Marsden, J; Shuster, S | 1 |
| Brummitt, L; Burke, B; Cunliffe, WJ; Greenwood, R | 1 |
| Döring, HF; Ilgner, M | 1 |
| Bercovici, JP; Grulier, A | 1 |
| Apró, G; Sas, M | 1 |
| Ylöstalo, P | 1 |
| Hansted, B; Reymann, F | 1 |
| Cramers, M; Zachariae, H | 1 |
| Cyganek, A; Grzechocińska, B; Marianowski, L | 1 |
| Bennink, HJ; Dieben, TO; Theeuwes, A; Vromans, L | 1 |
| Dal Prato, L; Fabbri, R; Flamigni, C; Paradisi, R; Porcu, E; Venturoli, S | 1 |
| Gerhard, I; Matthes, J; Runnebaum, B | 1 |
| Balint-Perić, LA; Prelević, GM; Puzigaća, Z | 1 |
| Elstein, ME; Golland, IM | 1 |
| Gaspard, UJ; Humblet, DM; Jaminet, CB; Jandrain, BJ; Lefèbvre, PJ; Scheen, AJ | 1 |
| Erdmann, D; Schindler, AE; Schindler, EM | 1 |
| Aydinlik, S; Braunschweig, T; Gurr, S; Kaufmann, J; Klinger, G; Schelhorn, P; Siegert, C; Wendler, J | 1 |
| Dramusic, V; Goh, VH; Rajan, U; Ratnam, SS; Wong, YC | 1 |
| Cicinelli, E; D'Addario, V; De Pergola, G; De Salvia, MA; Schonauer, LM; Tartagni, M | 1 |
| Regidor, M; Regidor, PA; Schindler, EM; Speer, K | 1 |
| Kleinstein, J; Muenstermann, U | 1 |
| Dilber, S; Keleştimur, F; Sahin, Y | 1 |
| Degreef, H; Tan, JK | 1 |
| Belaisch-Allart, J; Cornier, E; el Amrani, R; Henry-Suchet, J; Loysel, T; Mayenga, JM; Sarjdine, K | 1 |
| Borelli, C | 1 |
| Wooltorton, E | 1 |
| Ford, AR; Lexchin, J; Lippman, A; Mintzes, B | 1 |
| Rowe, TC | 1 |
| Koyuncu, FM; Kuscu, NK; Onur, E; Var, A | 1 |
| Kirim, S; Sert, M; Tetiker, T | 1 |
| Brzezińska-Wcisło, L | 1 |
| Herer, P; Luboshitzky, R; Shen-Orr, Z | 1 |
| Kelestimur, F; Sahin, Y | 1 |
| Chen, CY; Chen, PH; Hsieh, BC; Huang, LW; Huang, SC; Hwang, JL; Lin, YH; Seow, KM; Tsai, YL; Tzeng, CR; Wu, GJ | 1 |
| Mitkov, M; Pekhlivanov, B; Terzieva, D | 1 |
| Mitkov, M; Pehlivanov, B; Terzieva, D | 1 |
| Buyukberber, NM; Gulsen, MT; Kadayifci, A; Karaca, M | 1 |
| Chen, LS; Zhou, JT | 1 |
| Inal, MM; Taner, CE; Yildirim, Y | 1 |
| Foltyn, W; Kos-Kudła, B; Kudła, M; Mazur, B; Małecka-Mikosz, O; Ostrowska, Z | 1 |
| Dvorakova, K; Hill, M; Starka, L; Vrbikova, J | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Lasunción, MA; Luque-Ramírez, M; Martínez-Bermejo, E | 1 |
| Atanasova, I; Genchev, G; Kamenov, Z; Khristov, V; Kolarov, G; Milcheva, B; Orbetsova, M; Shigarminova, R; Zakharieva, S | 1 |
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Luque-Ramírez, M; San Millán, JL; Sanchón, R | 1 |
| Alvarez-Blasco, F; Escobar-Morreale, HF; Luque-Ramírez, M; Uriol Rivera, MG | 1 |
| Aral, Y; Bavbek, N; Culha, C; Demirbas, B; Güler, S; Karakurt, F; Sahin, I; Serter, R | 1 |
| Jiang, M; Ma, F; Qi, J; Qiao, L; Wang, L; Xie, S; Xu, K; Yue, H; Zhang, W; Zhou, X | 1 |
| Liao, H; Luo, WY; Sun, Y; Wang, CF; Zhang, D | 1 |
| Akcay, A; Bavbek, N; Gumus, II; Karakurt, F; Kargili, A; Koca, C; Kosar, A; Ozbek, M; Selcoki, Y | 1 |
| Jing, Z; Liang-Zhi, X; Tai-Xiang, W; Ying, T; Yu-Jian, J | 1 |
| del Rey Sánchez, JM; Escobar-Morreale, HF; Luque-Ramírez, M; Matíes, M; Mendieta-Azcona, C | 1 |
| Gui, SQ; Kuek, S; Wang, WJ | 1 |
| Demirlenk, S; Karabulut, A; Sevket, O | 1 |
| Gai, L; Gai, P; Jia, Y; Liu, Y; Shi, H; Wang, S; Yu, X; Zhang, M | 1 |
| Chacón, MR; de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Maymó-Masip, E; Salvador, C; Vendrell, J | 1 |
| Halilova, N | 1 |
| Collier, R | 1 |
| de Zegher, F; Díaz, M; Ibáñez, L; López-Bermejo, A; Marcos, MV; Sebastiani, G | 1 |
| Revuz, J | 2 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Açmaz, G; Boztosun, A; Müderris, II; Ozturk, A | 1 |
| Dixit, S; Fischer, G; Olsson, A | 1 |
| Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
| Arie, S | 1 |
| Jeerakathil, T; Kromm, J | 1 |
| Chan, SS; Chung, JP; Chung, TK; Yiu, AK | 1 |
| Armutcu, F; Carlioglu, A; Gumus, II; Karakurt, F; Kasapoglu, B; Kaygusuz, I; Keskin, EA; Koca, C; Uysal, A; Uysal, S | 1 |
| Kant, AC; van Hunsel, FP; van Puijenbroek, EP | 1 |
| Rosendaal, FR | 1 |
| Kant, A; van Hunsel, F; van Puijenbroek, E | 1 |
| Aksoy, A; Carlioglu, A; Gozukara, I; Kabil Kucur, S; Kamalak, Z; Keskin, H; Uludag, EU | 1 |
| Cahill, DJ; O'Brien, K | 1 |
| Jin, CL; Wei, LX; Wu, ZC; Zhao, JP | 1 |
| Carter, B; Fedorowicz, Z; Pandis, N; van Zuuren, EJ | 1 |
| Jin, J; Mueck, AO; Ruan, X; Wu, H | 1 |
| Chen, A; Du, J; Du, Y; Liao, YC; Lin, XF; Wang, Y; Wu, C; Wu, RR; Ye, Y; Zhang, XB | 1 |
| Aritürk, N; Eski Yücel, O; Gül, A; Güngor, I; Turgut, M | 1 |
| Feng, W; Jia, YY; Shi, HR; Zhang, DY | 1 |
| de Zegher, F; Díaz, M; Gallego-Escuredo, JM; Ibáñez, L; Villarroya, F | 1 |
| Mao, XG; Tu, AS; Zhong, Y | 1 |
| Asiimwe, A; Cea Soriano, L; García Rodriguez, LA | 1 |
| Cui, N; Feng, X; Hao, G; Wang, L; Xu, Y; Zhang, J; Zhao, Z | 1 |
| Cassano, N; Cricelli, C; Cricelli, I; Lapi, F; Simonetti, M; Vena, GA | 1 |
| Bitzer, J; Lopes da Silva Filho, A; Römer, T | 1 |
| Aguilar, A; Kubba, A; Mueck, AO; Ruan, X | 1 |
| Asiimwe, A; Bezemer, ID; Herings, RMC; Penning-van Beest, FJA; Smits, E | 1 |
| Gu, M; Mueck, AO; Ruan, X; Song, J; Wang, H; Wang, L | 2 |
| Cao, Y; Liu, Z; Zhang, L; Zhao, D | 1 |
| Cai, G; Du, J; Li, X; Li, Y; Mueck, AO; Ruan, X; Wang, H; Wang, L; Zhao, Y | 1 |
| Biancardi, MF; Campos, MS; Castro, CH; Falleiros-Júnior, LR; Marques, MR; Pinto, EG; Santos, FCA; Taboga, SR | 1 |
| Mohanty, J; Nagy, A; Sahu, A; Tripathy, P | 1 |
| Shi, Y; Tang, L; Ye, J; Zhu, X | 1 |
| Cao, Y; Chen, H; Liu, Z; Yu, X; Zhang, L; Zhao, D; Zhou, X | 1 |
| Chen, H; Cheng, NCL; Lim, CED; Ng, RWC; Zhang, GS | 1 |
| Asiimwe, A; Bezemer, ID; Cea Soriano, L; García Rodríguez, LA; Herings, RMC; Lapi, F; Penning-van Beest, FJA; Simonetti, M; Smits, E | 1 |
| Huo, P; Jiang, Z; Le, J; Lei, X; Tang, Q; Tu, H; Yao, J; Zhang, R; Zhang, S | 1 |
| Deng, Y; Ma, RL; Ma, X; Sun, AJ; Wang, YF; Xue, W; Zhu, SY | 1 |
| Hu, H; Li, F; Li, W; Liu, J; Ma, Z; Zou, G | 1 |
| Abdel-Maboud, M; Abdelraoof, MI; Alshandidy, M; Eid, M; Hasabo, EA; Menshawy, A; Menshawy, E; Outani, O | 1 |
| Álvarez-Blasco, F; de Lope Quiñones, S; Escobar-Morreale, HF; Fernández-Durán, E; Insenser, M; Luque-Ramírez, M; Martínez-García, MÁ; Nattero-Chávez, L; Ortiz-Flores, AE; Quintero-Tobar, A | 1 |
| Chen, X; Feng, Y; Li, X; Liu, Y; Wang, Y; Yao, D; Zhang, F | 1 |
9 review(s) available for cyproterone acetate and cyproterone acetate, ethinyl estradiol drug combination
| Article | Year |
|---|---|
Dianette for women with acne.
Topics: Acne Vulgaris; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1990 |
Acne vulgaris. The past. The present and the future.
Topics: Acne Vulgaris; Androgen Antagonists; Androgens; Benzoyl Peroxide; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Erythromycin; Ethinyl Estradiol; Female; Humans; Isotretinoin; Male; Propionibacterium acnes; Sebum; Tetracycline; Tretinoin | 1985 |
Medical treatment regimens of hirsutism.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2004 |
The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.
Topics: Algorithms; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Treatment Outcome | 2008 |
Interventions for hirsutism (excluding laser and photoepilation therapy alone).
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Body Mass Index; Contraceptive Agents, Female; Cyproterone Acetate; Desogestrel; Drug Combinations; Eflornithine; Ethinyl Estradiol; Female; Finasteride; Flutamide; Hirsutism; Humans; Hypoglycemic Agents; Metformin; Quality of Life; Randomized Controlled Trials as Topic; Spironolactone | 2015 |
The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms - a review.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Skin Diseases; Treatment Outcome | 2017 |
Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Treatment Outcome | 2017 |
Acupuncture for polycystic ovarian syndrome.
Topics: Abortion, Spontaneous; Acupuncture Therapy; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Menstruation; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Pregnancy, Multiple; Randomized Controlled Trials as Topic | 2019 |
The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
Topics: Adult; Body Mass Index; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Network Meta-Analysis; Obesity; Overweight; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Testosterone; Treatment Outcome; Triglycerides; Waist-Hip Ratio | 2021 |
48 trial(s) available for cyproterone acetate and cyproterone acetate, ethinyl estradiol drug combination
| Article | Year |
|---|---|
An open study of Triphasil and Diane 50 in the treatment of acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Synthetic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hormones; Humans; New Zealand; Norgestrel | 1991 |
Comparative study on the effect of Diane and Microgynon 50 contraceptive on the haemostatic mechanisms in Chinese subjects.
Topics: Adult; Asian People; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hemostasis; Humans; Norgestrel; Singapore | 1990 |
Hemorheological effects of oral contraceptives.
Topics: Adult; Blood Viscosity; Contraceptives, Oral; Cross-Sectional Studies; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Hematocrit; Humans; Longitudinal Studies; Norgestrel; Randomized Controlled Trials as Topic; Rheology | 1989 |
Anti-androgen treatment in women with acne: a controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Norethindrone; Norethindrone Acetate; Random Allocation | 1986 |
[Reduced estrogen ovulation inhibitor in acne therapy. Double-blind study comparing Diane-35 to Diane].
Topics: Acne Vulgaris; Adult; Clinical Trials as Topic; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1986 |
Clinical efficacy and safety of cyproterone acetate in severe hirsutism: results of a multicentered Canadian study.
Topics: Adolescent; Adult; Amenorrhea; Body Weight; Breast Diseases; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Random Allocation; Time Factors | 1986 |
[Clinical experience with Diane-35, currently the lowest dose antiandrogenic hormonal ovulation inhibitor, in mild to moderative androgenization in the female].
Topics: Acne Vulgaris; Adult; Alopecia; Androgen Antagonists; Clinical Trials as Topic; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Menstrual Cycle; Middle Aged | 1986 |
Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study.
Topics: Acne Vulgaris; Adolescent; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Norgestrel; Random Allocation | 1986 |
Effects of cyproterone acetate plus ethinylestradiol low dose on plasma androgens and lipids in mildly hirsute or acneic young women.
Topics: Acne Vulgaris; Adolescent; Adult; Androgens; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Lipids; Sex Hormone-Binding Globulin; Triglycerides | 1988 |
Cyclic cyproterone/ethinyloestradiol for acne.
Topics: Acne Vulgaris; Androgen Antagonists; Animals; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans; Rats; Sebum | 1983 |
The effects of CTR-24, a biphasic oral contraceptive combination, compared to Diane-35 in women with acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1994 |
The induction of ovulation with pulsatile gonadotrophin-releasing hormone (GnRH) administration in hyperandrogenic women after down-regulation with buserelin or suppression with an oral contraceptive.
Topics: Adult; Buserelin; Contraceptives, Oral, Combined; Cyproterone Acetate; Down-Regulation; Drug Combinations; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Hyperandrogenism; Infertility, Female; Infusion Pumps; Ovulation Induction | 1993 |
Results of an open one-year study with Diane-35 in women with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Tolerance; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Ultrasonography | 1993 |
[Ovarian suppression with Diane 35/50].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Treatment Outcome | 1994 |
The influence of Microgynon and Diane-35, two sub-fifty ovulation inhibitors, on voice function in women.
Topics: Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Ovulation; Phonation; Single-Blind Method | 1995 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Treatment Outcome | 2000 |
[Long-term side-effects following cyproterone acetate containing therapy in gynecology].
Topics: Adult; Androgen Antagonists; Carcinoma, Hepatocellular; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Liver Neoplasms; Risk Factors | 2000 |
Long-term GnRH analogue treatment is equivalent to laparoscopic laser diathermy in polycystic ovarian syndrome patients with severe ovarian dysfunction.
Topics: Adult; Androgen Antagonists; Chorionic Gonadotropin; Clomiphene; Cyproterone Acetate; Drug Combinations; Electrocoagulation; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Laparoscopy; Lasers; Leuprolide; Ovary; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Prospective Studies; Recombinant Proteins | 2000 |
Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
Topics: 5-alpha Reductase Inhibitors; Adult; Androgen Antagonists; Androstenedione; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Ethinyl Estradiol; Female; Finasteride; Hirsutism; Humans; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2001 |
[Comparison of 2 therapeutic strategies in severe endometriosis, in young women consulting for sterility or pain. II. In the case of infertility, value of ovarian stimulation with intrauterine insemination after surgery].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Endometriosis; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Insemination, Artificial; Laparoscopy; Ovulation Induction; Pregnancy; Recurrence; Retrospective Studies | 2001 |
Leptin levels in patients with polycystic ovary syndrome in response to two different oral contraceptive treatments.
Topics: Administration, Oral; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Leptin; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Steroids | 2003 |
Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Spironolactone; Testosterone | 2003 |
Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormone Antagonists; Hormones; Humans; Incidence; Infertility, Female; Menotropins; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pilot Projects; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome; Pregnancy Rate; Premedication | 2004 |
[Combined use of metformin and Diane35 in polycystic ovary syndrome].
Topics: Administration, Oral; Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Treatment Outcome | 2004 |
Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Body Mass Index; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone; Waist-Hip Ratio | 2005 |
[Clinical research on combined therapy of diane-35 with modified yougui pill on polycystic ovarian syndrome].
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Phytotherapy; Polycystic Ovary Syndrome; Tablets | 2005 |
Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Diuretics; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Prospective Studies; Spironolactone; Treatment Outcome | 2005 |
Plasma ghrelin concentrations in patients with polycystic ovary syndrome before and after 6months therapy: correlation with androgen levels.
Topics: Adult; Androgen Antagonists; Androgens; Androstenedione; Cyproterone Acetate; Dehydroepiandrosterone; Drug Combinations; Ethinyl Estradiol; Female; Ghrelin; Humans; Peptide Hormones; Polycystic Ovary Syndrome; Testosterone | 2006 |
Weight change and androgen levels during contraceptive treatment of women affected by polycystic ovary.
Topics: Adult; Androgens; Body Weight; Contraception; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipids; Polycystic Ovary Syndrome; Weight Gain | 2006 |
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androgens; Blood Glucose; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Dyslipidemias; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2007 |
Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Ferritins; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Iron; Metformin; Obesity; Oligomenorrhea; Polycystic Ovary Syndrome | 2007 |
Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
Topics: Adolescent; Adult; Body Mass Index; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Metformin; Obesity; Polycystic Ovary Syndrome; Risk Factors; Uric Acid | 2008 |
Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Lipids; Prospective Studies; Spironolactone; Young Adult | 2008 |
Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.
Topics: Adult; Androgen Antagonists; Blood Coagulation; Blood Platelets; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Endothelium, Vascular; Ethinyl Estradiol; Female; Fibrinogen; Homocysteine; Humans; Hypoglycemic Agents; Metformin; Obesity; Partial Thromboplastin Time; Polycystic Ovary Syndrome; Prothrombin; Smoking; Young Adult | 2009 |
Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Metformin; Phytotherapy; Polycystic Ovary Syndrome; Young Adult | 2011 |
Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
Topics: Absorptiometry, Photon; Adolescent; Adolescent Development; Bone and Bones; Bone Density; Bone Development; Bone Resorption; China; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Femur Neck; Humans; Lumbar Vertebrae; Medication Adherence; Patient Dropouts | 2012 |
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
Topics: Abdominal Fat; Adolescent; Androgen Antagonists; Angiopoietin-Like Protein 4; Angiopoietins; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Body Composition; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Flutamide; Gene Expression; Humans; Hyperandrogenism; Hypoglycemic Agents; Leptin; Metformin; Pioglitazone; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Subcutaneous Fat; Thiazolidinediones; TWEAK Receptor | 2012 |
Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
Topics: Adiposity; Adolescent; Adolescent Development; Androgen Antagonists; Body Mass Index; C-Reactive Protein; Carotid Intima-Media Thickness; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hyperinsulinism; Insulin Resistance; Intra-Abdominal Fat; Menstruation Disturbances; Overweight; Tunica Intima; Vascular Diseases | 2013 |
A randomized crossover study of medroxyprogesterone acetate and Diane-35 in adolescent girls with polycystic ovarian syndrome.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cross-Over Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Hyperandrogenism; Luteinizing Hormone; Medroxyprogesterone Acetate; Polycystic Ovary Syndrome; Prospective Studies; Quality of Life; Severity of Illness Index; Testosterone; Young Adult | 2014 |
[Efficacy comparison between electroacupuncture and dyne-35 in treatment of polycystic ovary syndrome].
Topics: Acupuncture Points; Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Electroacupuncture; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Young Adult | 2014 |
Effects of ethinylestradiol-cyproterone acetate vs. pioglitazone-flutamide-metformin on plasma FGF21 levels in adolescent girls with androgen excess.
Topics: Adolescent; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Fibroblast Growth Factors; Flutamide; Hirsutism; Humans; Hyperandrogenism; Hyperinsulinism; Longitudinal Studies; Metformin; Pioglitazone; Thiazolidinediones | 2016 |
[
Topics: Acupuncture Points; Acupuncture Therapy; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Ovary; Pilot Projects; Polycystic Ovary Syndrome | 2017 |
Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Treatment Outcome | 2018 |
Doppler analysis of ovarian stromal blood flow changes after treatment with metformin versus ethinyl estradiol-cyproterone acetate in women with polycystic ovarian syndrome: A randomized controlled trial.
Topics: Adult; Androgen Antagonists; Androgens; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Insulin Resistance; Luteinizing Hormone; Metformin; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Regional Blood Flow; Testosterone; Ultrasonography, Doppler, Color; Waist Circumference | 2019 |
The efficacy of Tung's acupuncture for sex hormones in polycystic ovary syndrome: A randomized controlled trial.
Topics: Acupuncture; Acupuncture Therapy; Adult; Body Mass Index; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Humans; Polycystic Ovary Syndrome | 2019 |
Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2020 |
Therapeutic effects of puerarin on polycystic ovary syndrome: A randomized trial in Chinese women.
Topics: Administration, Oral; Adolescent; Adult; China; Cholesterol; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Isoflavones; Metformin; Obesity; Polycystic Ovary Syndrome; Primary Ovarian Insufficiency; Sex Hormone-Binding Globulin; Superoxide Dismutase; Tablets; Testosterone; Treatment Outcome; Young Adult | 2021 |
Bloodletting has no effect on the blood pressure abnormalities of hyperandrogenic women taking oral contraceptives in a randomized clinical trial.
Topics: Adult; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Bloodletting; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypertension; Polycystic Ovary Syndrome; Young Adult | 2021 |
85 other study(ies) available for cyproterone acetate and cyproterone acetate, ethinyl estradiol drug combination
| Article | Year |
|---|---|
Influence of oral contraceptive agents on kidney function and protein metabolism.
Topics: Adult; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Dietary Proteins; Drug Combinations; Ethinyl Estradiol; Female; Germany; Glomerular Filtration Rate; Humans; Kidney; Norpregnenes | 1992 |
Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
Topics: Adolescent; Adult; Carrier Proteins; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Insulin; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Luteinizing Hormone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1991 |
A role for a non-androgenic anovulant in the management of hirsutism.
Topics: Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Dexamethasone; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Testosterone | 1991 |
Minocycline-induced pigmentation occurring in two sisters.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Ethinyl Estradiol; Family; Female; Humans; Minocycline; Pigmentation Disorders; Skin Pigmentation | 1991 |
[Ischemic colitis caused by estrogen-antiestrogen combination].
Topics: Adult; Androgen Antagonists; Colitis; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Ischemia | 1991 |
[Long-term studies with an anti-androgen/estrogen combination preparation of its effectiveness, liver tolerance and lipid metabolism in females].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cholesterol, HDL; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans; Lipids; Liver Function Tests; Long-Term Care; Menstrual Cycle; Middle Aged | 1991 |
Deep venous thrombosis and antibodies to cyproterone acetate.
Topics: Adult; Androgen Antagonists; Antibodies; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Iliac Vein; Thrombosis | 1990 |
Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Androgen Antagonists; Androstenedione; Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholesterol; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Liver; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1990 |
[Anti-androgen treatment of hirsutism with cyproterone acetate].
Topics: Administration, Oral; Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Injections, Intramuscular | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Apolipoproteins; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Lipid Metabolism; Male; Polycystic Ovary Syndrome; Triglycerides | 1990 |
Hereditary angioedema and oral contraception.
Topics: Adult; Androgen Antagonists; Angioedema; Contraceptives, Oral; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1990 |
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin | 1989 |
[Current status of gynecologic hormone therapy. Hyperandrogen disorders].
Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Testosterone | 1985 |
Comments on 'Conception during 'Diane' therapy--a successful outcome'.
Topics: Cyproterone; Cyproterone Acetate; Drug Combinations; Embryonic and Fetal Development; Ethinyl Estradiol; Female; Humans; Male; Pregnancy | 1986 |
On therapeutic approaches to some special types of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Cyproterone; Cyproterone Acetate; Diazepam; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Male; Sulfamethoxazole; Tetracycline; Tretinoin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
The management of acne in general practice.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Benzoyl Peroxide; Cyproterone; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Family Practice; Female; Humans; Male | 1985 |
Pulmonary embolism after short-term treatment of acne vulgaris with ovulation suppressor agents.
Topics: Acne Vulgaris; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pulmonary Embolism; Smoking | 1986 |
[Experience in treating androgen-dependent diseases (androgenetic alopecia, acne agminata, hirsutism) with the preparation Diane].
Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Follow-Up Studies; Hirsutism; Humans | 1986 |
[A cyproterone acetate-ethinyl estradiol combination in the treatment of acne. Data of a survey of gynecologists].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Gynecology; Humans; Surveys and Questionnaires | 1988 |
[Acne: long-term therapy with side effect. Sebaceous gland activity is androgen dependent--acne therapeutic drug is effective as a contraceptive].
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1988 |
[Pregnancy carried to term following administration of cyproterone acetate in the 1st trimester].
Topics: Abnormalities, Drug-Induced; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Trimester, First | 1988 |
[Inhibition of ovulation with 35 micrograms of ethinyl estradiol and 2 mg of cyproterone acetate (Diane 35)].
Topics: Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstrual Cycle; Ovulation; Progesterone | 1986 |
[Effects of an anti-androgen combination preparation on the hemostatic system].
Topics: Adolescent; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk; Thrombosis | 1987 |
Marked deciliation and insufficient secretory modification of endometrial surface during treatment with a new progestogen-estrogen combination.
Topics: Adolescent; Adult; Androgen Antagonists; Cilia; Cyproterone; Cyproterone Acetate; Drug Combinations; Endometrium; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Microscopy, Electron, Scanning | 1987 |
A comparative study of Aldactone and Diane in the treatment of hirsutism.
Topics: Adolescent; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Evaluation; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Pituitary Hormones, Anterior; Sex Hormone-Binding Globulin; Spironolactone | 1987 |
Cyclic cyproterone/ethinyloestradiol for acne.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 1983 |
Cyclic cyproterone/ethinyloestradiol for acne.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans; Sex Factors | 1983 |
Cyclic cyproterone/ethinyloestradiol in acne.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans | 1983 |
[Treatment of moderately severe virilism of women with Diane and Androcur 10].
Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hirsutism; Humans; Middle Aged; Virilism | 1983 |
[Cyproterone acetate (2 mg) controversy].
Topics: Acne Vulgaris; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Sebum | 1984 |
[Management of virilization with an antiandrogen-containing contraceptive].
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Testosterone; Virilism | 1981 |
[Diagnosis and treatment of hirsutism].
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Dexamethasone; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Spironolactone | 1984 |
[Diane].
Topics: Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Skin Diseases | 1983 |
Porphyria variegata treated with cyproterone acetate and ethinyl estradiol.
Topics: Abdomen; Adult; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Pain; Porphyrias; Skin Diseases | 1983 |
[Clinical treatment results of treating androgenization symptoms in women with preparation Diane-35].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Ethinyl Estradiol; Female; Humans; Remission Induction; Treatment Outcome; Virilism | 1994 |
Frequency and treatment of ovarian cysts in adolescence.
Topics: Adolescent; Androgen Antagonists; Child; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; Ovarian Cysts; Time Factors; Ultrasonography | 1994 |
Effects of an oral contraceptive containing cyproterone acetate (Diane-35) on the symptoms, hormone profile, and ovarian volume of hirsute women with polycystic ovarian syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Contraceptives, Oral; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hirsutism; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome | 1993 |
Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism.
Topics: Adult; C-Peptide; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Metabolic Clearance Rate | 1993 |
Clinical, endocrinologic, and ultrasonographic features of polycystic ovary syndrome in Singaporean adolescents.
Topics: Adolescent; Adult; Androgen Antagonists; Body Weight; Child; Cyproterone Acetate; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; Singapore; Testosterone; Ultrasonography | 1997 |
Oral contraceptives in the treatment of acne.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Androgens; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Humans; United States | 2001 |
[Cyproterone acetate].
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans | 2002 |
Diane-35 (cyproterone acetate): safety concerns.
Topics: Androgen Antagonists; Canada; Consumer Product Safety; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Factors; United Kingdom; Venous Thrombosis; Women's Health | 2003 |
Too much disclosure of product risks? CBC television, SOGC, and Diane-35.
Topics: Acne Vulgaris; Advertising; Androgen Antagonists; Canada; Cyproterone Acetate; Disclosure; Drug Combinations; Ethinyl Estradiol; Female; Humans; Odds Ratio; Risk Factors; United States; Venous Thrombosis | 2003 |
First-use risks.
Topics: Androgen Antagonists; Canada; Consumer Product Safety; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Risk Assessment; Risk Factors; Thromboembolism; Venous Thrombosis | 2003 |
[Assessment of efficacy of Diane-35 in androgenetic feminine alopecia].
Topics: Adult; Alopecia; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Hair; Humans; Time Factors; Treatment Outcome | 2003 |
DISASTER operations of the Pennsylvania Department of Health in Hurricane Diane.
Topics: Cyclonic Storms; Cyproterone Acetate; Disasters; Drug Combinations; Ethinyl Estradiol; Humans; Pennsylvania | 1955 |
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
Cyproterone acetate and ethinylestradiol-induced pill oesophagitis: a case report.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Esophagitis; Esophagoscopy; Ethinyl Estradiol; Female; Hirsutism; Humans; Tablets; Ulcer | 2005 |
[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy].
Topics: Androgen Antagonists; Blood Glucose; Body Composition; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Polycystic Ovary Syndrome; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome | 2006 |
Homeostasis model assessment-insulin resistance (HOMA-IR), a key role for assessing the ovulation function in polycystic ovary syndrome (PCOS) patients with insulin resistance.
Topics: Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Homeostasis; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Models, Biological; Ovarian Follicle; Ovary; Ovulation; Polycystic Ovary Syndrome; Sensitivity and Specificity | 2008 |
[The effects of oxidative stress to PCOS].
Topics: Androgen Antagonists; Antioxidants; Ascorbic Acid; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Lipid Peroxides; Malondialdehyde; Oxidative Stress; Polycystic Ovary Syndrome; Superoxide Dismutase; Vitamin E | 2008 |
Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome.
Topics: Adult; Antigens; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Models, Biological; Polycystic Ovary Syndrome; Risk Factors; Thrombosis; Up-Regulation; Young Adult | 2008 |
Effects of ethinyl estradiol-cyproterone acetate treatment on metabolic syndrome, fat distribution and carotid intima media thickness in polycystic ovary syndrome.
Topics: Adiposity; Adolescent; Adult; Androgen Antagonists; Body Fat Distribution; Carotid Intima-Media Thickness; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin Resistance; Metabolic Syndrome; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2012 |
Improving the prognosis ways of central genesis and management option in infertile women.
Topics: Adolescent; Adult; Amenorrhea; Androgen Antagonists; Carbamazepine; Central Nervous System Diseases; Cinnarizine; Cyproterone Acetate; Desogestrel; Drug Combinations; Electroencephalography; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oligomenorrhea; Progestins; Prognosis; Treatment Outcome; Young Adult | 2012 |
Scrutiny of Diane-35 due to potential dangers of off-label prescribing.
Topics: Canada; Cyproterone Acetate; Drug Combinations; Drug Labeling; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Ethinyl Estradiol; Female; Humans; Off-Label Use; Safety-Based Drug Withdrawals | 2013 |
[The hypocrisy of Diane®].
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Polycystic Ovary Syndrome; Severity of Illness Index; Treatment Outcome; Women's Health; Young Adult | 2013 |
A case series of 11 patients with hormone-responsive sebaceous adenitis of the labia minora.
Topics: Adolescent; Adult; Androgen Antagonists; Anti-Bacterial Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Inflammation; Middle Aged; Sebaceous Gland Diseases; Spironolactone; Tetracyclines; Vulvar Diseases | 2014 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
European Commission orders France to lift ban on acne pill.
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral; Cyproterone Acetate; Drug Administration Schedule; Drug Combinations; Drug Labeling; Ethinyl Estradiol; European Union; Female; France; Humans; Pulmonary Embolism; Safety-Based Drug Withdrawals; Thrombosis | 2013 |
[Oral contraceptives, risks and hazards].
Topics: Acne Vulgaris; Androgen Antagonists; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; European Union; Female; France; Hirsutism; Humans; Risk Assessment; Safety-Based Drug Withdrawals | 2014 |
Cyproterone acetate-ethinyl estradiol use in a 23-year-old woman with stroke.
Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Magnetic Resonance Imaging; Stroke; Tomography, X-Ray Computed; Young Adult | 2014 |
The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Androgen Antagonists; Aryldialkylphosphatase; Body Mass Index; Carboxylic Ester Hydrolases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Lipoproteins, LDL; Metformin; Phospholipase A2 Inhibitors; Platelet Activating Factor; Polycystic Ovary Syndrome; Polymorphism, Single Nucleotide; Treatment Outcome | 2014 |
[Thrombosis and embolism during Diane-35 use: analysis of reports made to the Netherlands Pharmacovigilance Centre Lareb].
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Embolism; Ethinyl Estradiol; Female; Humans; Male; Netherlands; Pharmacovigilance; Risk Factors; Thrombosis | 2014 |
[Pill matters: targeted research into side effects necessary].
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Embolism; Ethinyl Estradiol; Female; Humans; Male; Pharmacovigilance; Thrombosis | 2014 |
Reflections after the Diane affair.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Cyproterone Acetate; Drug Combinations; Drug Industry; Ethinyl Estradiol; Female; France; Humans; Pharmacovigilance; Thrombosis | 2014 |
How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Blood Platelets; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Leukocyte Count; Mean Platelet Volume; Metformin; Polycystic Ovary Syndrome; Regression Analysis; Treatment Outcome | 2015 |
Polycystic ovary syndrome (PCOS): metformin.
Topics: Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Weight Reduction Programs | 2015 |
Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Topics: Adolescent; Adult; Androgen Antagonists; China; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Metabolome; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Young Adult | 2015 |
Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
Topics: Abortion, Spontaneous; Adult; Androgen Antagonists; Blood Glucose; Body Mass Index; Clomiphene; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estradiol; Ethinyl Estradiol; Female; Fertility Agents, Female; Follicle Stimulating Hormone; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Live Birth; Luteinizing Hormone; Metformin; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Prolactin; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome; Young Adult | 2015 |
Papillophlebitis associated with the use of oral contraceptive: a case report.
Topics: Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Ovarian Cysts; Papilledema; Young Adult | 2015 |
Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin.
Topics: Adult; Androgen Antagonists; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Outcome Assessment, Health Care; Polycystic Ovary Syndrome; Young Adult | 2016 |
[Changes of serum TOS and TAS levels and their association with apolipoprotein(a) in patients with polycystic ovary syndrome and infertility].
Topics: Antioxidants; Apoprotein(a); Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Oxidative Stress; Polycystic Ovary Syndrome | 2016 |
Prescribing of cyproterone acetate/ethinylestradiol in UK general practice: a retrospective descriptive study using The Health Improvement Network.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Databases, Factual; Drug Combinations; Ethinyl Estradiol; Female; General Practice; Hirsutism; Humans; Hyperandrogenism; Off-Label Use; Polycystic Ovary Syndrome; Retrospective Studies; United Kingdom; Young Adult | 2017 |
Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin.
Topics: Adult; Amidohydrolases; Androgen Antagonists; Arachidonic Acids; Cyproterone Acetate; Drug Combinations; Endocannabinoids; Endometrium; Ethinyl Estradiol; Female; Glycerides; Humans; Infertility, Female; Metformin; Polycystic Ovary Syndrome; Polyunsaturated Alkamides; Receptors, Cannabinoid; Young Adult | 2017 |
Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy.
Topics: Acne Vulgaris; Adolescent; Adult; Cyproterone Acetate; Drug Combinations; Drug Utilization; Ethinyl Estradiol; Female; Humans; Middle Aged; Primary Health Care; Young Adult | 2017 |
Thrombotic risk minimization for Diane-35 and generics.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Androgen Antagonists; Cohort Studies; Cyproterone Acetate; Databases, Factual; Drug Combinations; Drug Utilization; Drugs, Generic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Menstruation Disturbances; Middle Aged; Netherlands; Retrospective Studies; Risk Reduction Behavior; Thrombosis; Young Adult | 2017 |
Effect of orlistat or metformin in overweight and obese polycystic ovary syndrome patients with insulin resistance.
Topics: Adult; Anti-Obesity Agents; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lactones; Metformin; Obesity; Orlistat; Overweight; Polycystic Ovary Syndrome; Young Adult | 2018 |
Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
Topics: Adult; Androgen Antagonists; Birth Weight; China; Clomiphene; Cyproterone Acetate; Diabetes, Gestational; Drug Combinations; Ethinyl Estradiol; Female; Fertility Agents, Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Infertility, Female; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Complications; Premature Birth; Prevalence; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Time-to-Pregnancy; Treatment Outcome; Young Adult | 2018 |
Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene's paraurethral glands) of adult gerbils (Meriones unguiculatus).
Topics: Animal Structures; Animals; Contraceptives, Oral, Combined; Cyproterone Acetate; DNA Modification Methylases; Drug Combinations; Estrogen Receptor alpha; Ethinyl Estradiol; Female; Genitalia, Female; Gerbillinae; Immunohistochemistry; Male; Microscopy, Electron, Transmission; Proliferating Cell Nuclear Antigen; Prostate; Receptors, Androgen; Up-Regulation; Urethra; Vagina | 2018 |
Association between CD16
Topics: Adult; Biomarkers; Case-Control Studies; China; Cross-Sectional Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Insulin Resistance; Metformin; Monocytes; Polycystic Ovary Syndrome; Prospective Studies; Receptors, IgG | 2019 |
Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy.
Topics: Acne Vulgaris; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Humans; Italy; Netherlands; Retrospective Studies; United Kingdom | 2020 |
Combined use of Diane-35 and metformin improves the ovulation in the PCOS rat model possibly via regulating glycolysis pathway.
Topics: Androgen Antagonists; Animals; Apoptosis; Body Weight; Cyproterone Acetate; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Female; Glycolysis; Hypoglycemic Agents; Insulin Resistance; Lactate Dehydrogenase 5; Luteinizing Hormone; Metformin; Ovary; Ovulation; Polycystic Ovary Syndrome; Pyruvate Kinase; Rats; Sirtuin 1; Testosterone | 2020 |
Diane-35 and Metformin Induce Autophagy and Apoptosis in Polycystic Ovary Syndrome Women with Early-Stage Endometrial Carcinoma.
Topics: Androgen Antagonists; Animals; Apoptosis; Autophagy; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Endometrial Neoplasms; Ethinyl Estradiol; Female; Glucose Transporter Type 4; Hypoglycemic Agents; Insulin-Like Growth Factor I; Metformin; Mice; Polycystic Ovary Syndrome; Receptors, Androgen | 2022 |